Dr. Tse Sau Mei - Rheumatology
Specialist in Rheumatology
Highlights
- MCHK RegisteredVerified
- Specialist in RheumatologyBachelor of Medicine and Bachelor of Surgery (MBChB) · Hong Kong College of Physicians · Medical degree 2008
- InsuranceBeing compiled｜See details
About
Dr. Tse Sau Mei is a registered Rheumatology specialist in Hong Kong.
Education
Specialist in Rheumatology
- Bachelor of Medicine and Bachelor of Surgery (MBChB)Bachelor of Medicine and Bachelor of Surgery (MBChB)2008
Hong Kong Academy of Medicine fellowships
- FHKCPFellow, Hong Kong College of Physicians
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Tse Sau Mei? Claim page and update insurance →
FAQ
Is Dr. Tse Sau Mei any good?
Dr. Tse Sau Mei is a registered Rheumatology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Tse Sau Mei do?
Dr. Tse Sau Mei practises in Rheumatology.
Are you Dr. Tse Sau Mei? Claim this page to update and manage.
ClaimResearch and publications
14 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Long-term immunogenicity of a live attenuated herpes zoster vaccine in patients with systemic lupus erythematosus.Vaccine · 2025
- Effect of SARS-CoV2 infection on disease flares in patients with systemic lupus erythematosus: a case-control study.Rheumatology (Oxford, England) · 2024
- Romosozumab versus denosumab in long-term users of glucocorticoids: A pilot randomized controlled trial.Journal of internal medicine · 2024
- Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.Clinical rheumatology · 2023
- De novo lupus nephritis after SARS-CoV-2 infection.Lupus · 2023
- Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Associated with Disease Activity and Risk of Incident Cardiovascular Disease in Patients with Systemic Lupus Erythematosus.Inflammation · 2023
- Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus.Vaccine · 2022
- Estimation of fracture risk by the FRAX tool in patients with systemic lupus erythematosus: a 10-year longitudinal validation study.Therapeutic advances in musculoskeletal disease · 2022
- Trend of Survival of a Cohort of Chinese Patients With Systemic Lupus Erythematosus Over 25 Years.Frontiers in medicine · 2020
- Prevalence and risk factors of herpes zoster infection in patients with biopsy proven lupus nephritis undergoing immunosuppressive therapies.Lupus · 2020
- Effect of the metabolic syndrome on organ damage and mortality in patients with systemic lupus erythematosus: a longitudinal analysis.Clinical and experimental rheumatology · 2018
- Prevalence of remission and its effect on damage and quality of life in Chinese patients with systemic lupus erythematosus.Annals of the rheumatic diseases · 2017
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer